BE463549A - - Google Patents

Info

Publication number
BE463549A
BE463549A BE463549DA BE463549A BE 463549 A BE463549 A BE 463549A BE 463549D A BE463549D A BE 463549DA BE 463549 A BE463549 A BE 463549A
Authority
BE
Belgium
Application number
Publication of BE463549A publication Critical patent/BE463549A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
BE463549D BE463549A (ja)

Publications (1)

Publication Number Publication Date
BE463549A true BE463549A (ja)

Family

ID=115612

Family Applications (1)

Application Number Title Priority Date Filing Date
BE463549D BE463549A (ja)

Country Status (1)

Country Link
BE (1) BE463549A (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069232A3 (en) * 1981-07-02 1984-07-04 Stanislaw R. Burzynski Purified antineoplaston fractions and methods of treating neoplastic disease
US4558057A (en) * 1981-12-15 1985-12-10 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4559325A (en) * 1981-12-15 1985-12-17 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069232A3 (en) * 1981-07-02 1984-07-04 Stanislaw R. Burzynski Purified antineoplaston fractions and methods of treating neoplastic disease
US4558057A (en) * 1981-12-15 1985-12-10 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4559325A (en) * 1981-12-15 1985-12-17 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease

Similar Documents

Publication Publication Date Title
DE69232426T2 (de) Zusammensetzungen zur behandlung und vorbeugung von krebs
EP0069232B1 (en) Pharmaceutical composition comprising phenyl acetyl glutamine,a combination of this compound with phenylacetic acid or 3-(phenylacetylamino)piperidine-2,6-dione,a process for isolating the latter from urine and a process for the synthesis of 3-(phenylacetylamino)piperidine-2,6-dione
US4558057A (en) Purified antineoplaston fractions and methods of treating neoplastic disease
WO1985000972A1 (en) Poly-cation salts of 4-o-polyhexaose-thio-arylene sulfates
US4559325A (en) Purified antineoplaston fractions and methods of treating neoplastic disease
US5116622A (en) Methods for treating parkinson's disease
FI92391B (fi) Menetelmä 3-(N-fenyyliasetyyliaminopiperidiini)-2,6-dionin valmistamiseksi